MARKET WIRETradingView • 1d ago
Pulsenmore Ltd. Estimates – TASE:PLSMTradingView report covering Pulsenmore Ltd. (PLSM) market action, institutional positioning, and fundamental catalysts.
Why PLSM Stock slipped -1.87% Today — RQD Quant Desk Flash
$1.64 -1.87% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $1.63
Pulsenmore Ltd. (PLSM) carries a Roarable Rating of D (Sell) with 47/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D • SELL / AVOID
Cap $10.9M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on PLSM Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is PLSM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Pulsenmore Ltd. (NASDAQ: PLSM) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $1.64 (-1.87% 1D, market cap $10.9M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1015 tracked Health Care issuers, PLSM ranks #316 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does PLSM compare to FEMY and ICU in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), PLSM carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, FEMY (Femasys Inc.) holds a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $11.5M) and ICU (SeaStar Medical Holding Corporation) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $11.8M). Among the 5-stock peer group, PLSM leads on earnings multiple (N/A) while FEMY leads on capital efficiency (-35.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for PLSM?
▼
For Pulsenmore Ltd. (PLSM), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity and sector rank #316 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $1.63 (-0.53%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D+
Each axis scored 0–20
12M PRICE TARGET CONE-4.9% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PLSM)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (47/100 Composite)
🔍 WHY PLSM SCORES 47/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (28% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)
SEC XBRL Trailing 12 Months: 0% FCF Margin ($304.1K FCF) & 52% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C$1.90-7.4% Next Q
55
Q2 (-2Q)Grade C-$1.76+1.7% Next Q
52
Q3 (-1Q)Grade C-$1.79-8.4% Next Q
50
CurrentGrade D$1.64-5.9% Hist 90D α
47
Trajectory: C (55) → D (47)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a PLSM Turnaround Squeeze
While PLSM currently carries a cautious 47/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.17) and Max Pain ($1.72) forces dealer call-delta covering toward $13.62.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $PLSM• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PLSM Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why PLSM Stock slipped -1.87% Today — RQD Quant Desk Flash
Pulsenmore Ltd. (PLSM) slipped -1.87% to $1.64, trading at 2% of its 52-week range ($1.57 – $12.97). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($1.57 – $12.97) with RSI-14 at 34.3 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.64 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 52% gross margin and $304073 annual free cash flow.
Live PLSM Headlines & Catalysts
MARKET WIRETradingView • 1d ago
Pulsenmore (PLSM) Appoints David Woods as Chief Commercial OfficerTradingView report covering Pulsenmore Ltd. (PLSM) market action, institutional positioning, and fundamental catalysts.
MARKET WIREhttps://www.dars.gov.et/ • 1d ago
Pulsenmore Ltd. (PLSM) Holds Steady at $1.78 as Traders Eye Support and Resistance - Gap and Reversehttps://www.dars.gov.et/ report covering Pulsenmore Ltd. (PLSM) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 21d ago
Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial OfficerPulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM) ("Pulsenmore" or the "Company"), a pioneer in patient-operated home ultrasound technology, today announced the appointment of David Woods as Chief Commercial Officer (CCO), alo
MARKET WIREBenzinga • 21d ago
Full Transcript: Pulsenmore H1 2026 Earnings CallPulsenmore (NASDAQ:PLSM) held its quarterly earnings conference call on Monday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts,
MARKET WIREYahoo Finance • 47d ago
Pulsenmore Expands Its Fertility Platform into the UKPulsenmore (NASDAQ: PLSM) (TASE: PLSM), a healthcare technology company developing self-use ultrasound solutions for remote care, today announced that it has completed the registration of Pulsenmore FC with the MHRA, the
MARKET WIREYahoo Finance • 56d ago
Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular MonitoringPulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a healthcare technology company developing self-use ultrasound solutions for remote care, today announced that it has completed the CE European registration process for Pulsen
MARKET WIREYahoo Finance • 71d ago
Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leading innovator in remote maternal-fetal healthcare and home ultrasound solutions, today announces that it will release its financial results and business highlights for t
MARKET WIREYahoo Finance • 76d ago
Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy MonitoringPulsenmore (NASDAQ: PLSM) (TASE: PLSM), a developer of home ultrasound solutions supported by remote medical guidance, today announced the expansion of its activities in Israel. The Company's home ultrasound technology w
MARKET WIREYahoo Finance • 78d ago
Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI ProgramPulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a global leader in home ultrasound technology, today announced that the Israel Innovation Authority has approved a grant of $1.27 million for the Company's SmartScan AI resear
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PLSM)
- ✓Walkthrough of PLSM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
PLSM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -51.34%⚡ TESTING RESISTANCE
2026-11-03O $1.62H $1.67L $1.62C $1.64VOL 11.3K
RES: $1.71SUP: $1.53SMA50: $2.17SMA200: $3.71
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
PLSM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on PLSM today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for PLSM. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PLSM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PLSM)
Health Care Rank #316 of 1015
⚔️ FEMY vs PLSM Full Matrix →
1. Head-to-Head Health Care Peer Comparison (PLSM vs. FEMY, ICU, SINT, CNSY)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, Pulsenmore Ltd. (PLSM) ranks #316 by composite RQD confidence (47/100, grade D) and #887 by equity capitalization ($10.9M). Within this direct 5-issuer industry benchmark cohort, PLSM leads on earnings valuation at N/A trailing P/E, while FEMY leads on capital efficiency and profitability with -35.0% ROIC and 62.0% gross margin. PLSM currently leads its immediate peer cohort in composite quantitative strength at 47/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| PLSM
ACTIVE
Pulsenmore Ltd. | D | 47/100 | — | — | — | -1.87% | $10.9M | Benchmark Subject |
| FEMY Femasys Inc. | E | 30/100 | — | 62.0% | -35.0% | -3.65% | $11.5M | /femy-vs-plsm → |
| ICU SeaStar Medical Holding Corporation | E | 31/100 | — | 95.7% | -35.0% | -2.23% | $11.8M | /icu-vs-plsm → |
| SINT SiNtx Technologies Inc. | E | 33/100 | — | 45.3% | -35.0% | +0.59% | $12.8M | /sint-vs-plsm → |
| CNSY Cerenome Inc. | E | 25/100 | — | — | -35.0% | +0.59% | $12.9M | /cnsy-vs-plsm → |
2. PLSM Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics
TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOTPulsenmore Ltd. (PLSM) operates in Medical/Dental Instruments (Health Care) with an equity capitalization of $10.9M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
3. PLSM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs PLSM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Pulsenmore Ltd. (NASDAQ: PLSM) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $1.64 (-1.87% 1D, market cap $10.9M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1015 tracked Health Care issuers, PLSM ranks #316 in composite RQD confidence.
How does PLSM compare to FEMY and ICU in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), PLSM carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, FEMY (Femasys Inc.) holds a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $11.5M) and ICU (SeaStar Medical Holding Corporation) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $11.8M). Among the 5-stock peer group, PLSM leads on earnings multiple (N/A) while FEMY leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for PLSM?
For Pulsenmore Ltd. (PLSM), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity and sector rank #316 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is PLSM trading relative to its 50-day, 200-day, and 52-week technical levels?
PLSM last traded at $1.64 (-1.87% on volume of 11,451 shares), positioning the stock -24.42% below its 50-day simple moving average ($2.17) and -55.80% below its 200-day simple moving average ($3.71). Across its 52-week range of $1.57 to $12.97, PLSM sits at the 0.6% percentile with a 14-day RSI of 34.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.44 to $1.84).
ROARABLE RATING BRIEF • RQD 47/100 (D)
✓ SEC XBRL & RQD VERIFIED
PLSM — Pulsenmore Ltd.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-11-03
1. Roarable Rating Brief: What This Means to a Prospective Investor
Pulsenmore Ltd. (PLSM) earns a live Roarable RQD composite score of 47/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $1.64 (-1.87% 1D, market capitalization $10.9M).
- Fundamental Cash Engine (12/20): Anchored by return on invested capital (ROIC) of —, gross margin of —, operating margin of —, and free cash flow yield of —.
- Whale 13F & Options Flow (3/20) + Insider Conviction (9/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (10/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of N/A, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Pulsenmore Ltd. Is a NASDAQ-listed issuer in the Health Care sector, Medical/Dental Instruments industry (per the company profile). The profile does not describe its products, customers, or revenue model; those details are — The company's market capitalization is listed as $0.0B in the profile, which differs from the $10.5M in market data.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D • RQD 47/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 3/20. With Fundamental Cash Engine at 12/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $1.57 – $12.97 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream suppliers, downstream customers, and sector-correlation mappings are therefore — The stock's sector (Health Care) and industry (Medical/Dental Instruments) are the only classification data available. A prospective investor should note that 2nd-order bottleneck analysis cannot be performed from the provided data.
- Key Question #1: Can PLSM sustain or expand its — operating margin and — ROIC against Medical/Dental Instruments peers over the next 4 quarters?
- Key Question #2: Will free cash flow conversion (— FCF yield) strengthen balance-sheet liquidity (Altman Z-Score N/A) toward the $12.97 52-week high?
- Key Question #3: How sensitive is PLSM's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
PLSM Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Pulsenmore Ltd. (PLSM) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE TradingView • 1d ago
Pulsenmore Ltd. Estimates – TASE:PLSM TradingView report covering Pulsenmore Ltd. (PLSM) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
Pulsenmore (PLSM) Appoints David Woods as Chief Commercial Officer TradingView report covering Pulsenmore Ltd. (PLSM) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE https://www.dars.gov.et/ • 1d ago
Pulsenmore Ltd. (PLSM) Holds Steady at $1.78 as Traders Eye Support and Resistance - Gap and Reverse https://www.dars.gov.et/ report covering Pulsenmore Ltd. (PLSM) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo • 21d ago
Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM) ("Pulsenmore" or the "Company"), a pioneer in patient-operated home ultrasound technology, today announced the appointment of David Woods as Chief Commercial Officer (CCO), alo
🟡 MARKET WIRE Benzinga • 21d ago
Full Transcript: Pulsenmore H1 2026 Earnings Call Pulsenmore (NASDAQ:PLSM) held its quarterly earnings conference call on Monday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts,
🟡 MARKET WIRE Yahoo Finance • 47d ago
Pulsenmore Expands Its Fertility Platform into the UK Pulsenmore (NASDAQ: PLSM) (TASE: PLSM), a healthcare technology company developing self-use ultrasound solutions for remote care, today announced that it has completed the registration of Pulsenmore FC with the MHRA, the
🟡 MARKET WIRE Yahoo Finance • 56d ago
Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a healthcare technology company developing self-use ultrasound solutions for remote care, today announced that it has completed the CE European registration process for Pulsen
🟡 MARKET WIRE Yahoo Finance • 71d ago
Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026 Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leading innovator in remote maternal-fetal healthcare and home ultrasound solutions, today announces that it will release its financial results and business highlights for t
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
PLSM Bull vs. Bear Conversation Board — What's Your Call at $1.64?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PLSM 🐻 33% BEARISH CONVICTION
DE DeepValue_CFA RQD DEBATE OPENER • Institutional Buy-Side 🐂 BULLISH
🎯 Target: $2.02 (+21.0%)
📌 Pinned Debate The forensic balance sheet pillar scores 13 of 20 with Altman Z of 2.5, Piotroski F of 6/9, and Debt/Equity of 0.5, its strongest readi
The forensic balance sheet pillar scores 13 of 20 with Altman Z of 2.5, Piotroski F of 6/9, and Debt/Equity of 0.5, its strongest reading in the rating.. When you look under the hood at PLSM, Fundamental Cash Engine is 12/20 with 0.0% gross margins and 0.0% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (3/20) has been quietly accumulating below $12.97. My 12M target is $2.02.
SectorRotator 🐂 BULL
@DeepValue_CFA Agree on the RQD 47/100 quality, though with 1.0 beta I'm scaling in with half-size at $1.67 and keeping dry powder in case we test $1.55.
FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH
🎯 Target: $1.32 (-21.0%)
Spot @ $1.67 The whale 13F flow pillar scores 3 of 20 and ROIC and FCF yield are both 0%, pointing to weak institutional support and no measured cas
Fading this rally in PLSM at $1.67. The whale 13F flow pillar scores 3 of 20 and ROIC and FCF yield are both 0%, pointing to weak institutional support and no measured cash generation.. With a beta of 1.0 and the stock sitting at $1.67 (52-wk range $1.57–$12.97), the easy multiple expansion is already priced in.